MedTrace Logo

Prednisolone Acetate Eye Drops for Pain Intervention in Second Eye Cataract Surgery

NCT06614348 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2024-09-26

No results posted yet for this study

Summary

This study aims to evaluate the efficacy, safety, and potential mechanisms of prednisolone acetate eye drops for pain management in patients undergoing second-eye surgery for age-related cataracts.

Researchers will compare prednisolone acetate eye drops to sodium hyaluronate eye drops to see if prednisolone acetate eye drops work to relieve intraoperative and postoperative pain during second-eye cataract surgery.

Participants will:

1. Receive prednisolone acetate eye drops or sodium hyaluronate eye drop four drops within 2 hours before cataract surgery
2. Finish cataract surgery and routine postoperative follow-up
3. Pain questionnaire completed after cataract surgery

Conditions

  • Age Related Cataract
  • Pain Management During Cataract Surgery

Interventions

DRUG

Prednisolone acetate eye drop group

Patients receive prednisolone acetate eye drops 4 times per 30min within 2 hours before cataract surgery

DRUG

Sodium hyaluronate eye drops

Patients receive sodium hyaluronate eye drops 4 times per 30min within 2 hours before cataract surgery

Sponsors & Collaborators

  • Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

    lead OTHER

Principal Investigators

  • Huiyi Jin · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-08
Primary Completion
2025-06-30
Completion
2025-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06614348 on ClinicalTrials.gov